Homocysteine level, body mass index and clinical correlates in Chinese Han patients with schizophrenia
Obesity is common comorbidity in patients with schizophrenia. Previous studies have reported that homocysteine (Hcy) is increased in schizophrenia. However, no study has reported the association between BMI and Hcy levels in schizophrenia. This cross-sectional naturalistic study aimed to evaluate the relationship between BMI, Hcy and clinical symptoms in Chinese Han patients with chronic schizophrenia. Clinical and anthropometric data as well as plasma Hcy level and glycolipid parameters were collected. Psychopathology was measured with the Positive and Negative Syndrome Scale (PANSS). Our results showed that compared with the low BMI group, the high BMI group had a higher PANSS general psychopathology subscore, higher levels of blood glucose, total cholesterol and high-density lipoprotein (HDL) cholesterol (all p < 0.05). Hcy levels were negatively associated with BMI in patients (p < 0.001). Hcy level, the PANSS general psychopathology subscale, total cholesterol and education (all p < 0.05) were the influencing factors of high BMI. Our study suggest that Hcy level may be associated with BMI in patients with schizophrenia. Moreover, patients with high BMI show more severe clinical symptoms and higher glucose and lipid levels.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2020 |
---|---|
Erschienen: |
2020 |
Enthalten in: |
Zur Gesamtaufnahme - volume:10 |
---|---|
Enthalten in: |
Scientific reports - 10(2020), 1 vom: 30. Sept., Seite 16119 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Huang, Yuanyuan [VerfasserIn] |
---|
Links: |
---|
Themen: |
0LVT1QZ0BA |
---|
Anmerkungen: |
Date Completed 04.01.2021 Date Revised 07.12.2022 published: Electronic Citation Status MEDLINE |
---|
doi: |
10.1038/s41598-020-72934-3 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM315698438 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | NLM315698438 | ||
003 | DE-627 | ||
005 | 20231226201957.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231225s2020 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1038/s41598-020-72934-3 |2 doi | |
028 | 5 | 2 | |a pubmed24n1052.xml |
035 | |a (DE-627)NLM315698438 | ||
035 | |a (NLM)32999343 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Huang, Yuanyuan |e verfasserin |4 aut | |
245 | 1 | 0 | |a Homocysteine level, body mass index and clinical correlates in Chinese Han patients with schizophrenia |
264 | 1 | |c 2020 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 04.01.2021 | ||
500 | |a Date Revised 07.12.2022 | ||
500 | |a published: Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a Obesity is common comorbidity in patients with schizophrenia. Previous studies have reported that homocysteine (Hcy) is increased in schizophrenia. However, no study has reported the association between BMI and Hcy levels in schizophrenia. This cross-sectional naturalistic study aimed to evaluate the relationship between BMI, Hcy and clinical symptoms in Chinese Han patients with chronic schizophrenia. Clinical and anthropometric data as well as plasma Hcy level and glycolipid parameters were collected. Psychopathology was measured with the Positive and Negative Syndrome Scale (PANSS). Our results showed that compared with the low BMI group, the high BMI group had a higher PANSS general psychopathology subscore, higher levels of blood glucose, total cholesterol and high-density lipoprotein (HDL) cholesterol (all p < 0.05). Hcy levels were negatively associated with BMI in patients (p < 0.001). Hcy level, the PANSS general psychopathology subscale, total cholesterol and education (all p < 0.05) were the influencing factors of high BMI. Our study suggest that Hcy level may be associated with BMI in patients with schizophrenia. Moreover, patients with high BMI show more severe clinical symptoms and higher glucose and lipid levels | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Research Support, Non-U.S. Gov't | |
650 | 7 | |a Blood Glucose |2 NLM | |
650 | 7 | |a Cholesterol, HDL |2 NLM | |
650 | 7 | |a Homocysteine |2 NLM | |
650 | 7 | |a 0LVT1QZ0BA |2 NLM | |
700 | 1 | |a Wu, Kai |e verfasserin |4 aut | |
700 | 1 | |a Li, Hehua |e verfasserin |4 aut | |
700 | 1 | |a Zhou, Jing |e verfasserin |4 aut | |
700 | 1 | |a Xiong, Dongsheng |e verfasserin |4 aut | |
700 | 1 | |a Huang, Xia |e verfasserin |4 aut | |
700 | 1 | |a Li, Jiahui |e verfasserin |4 aut | |
700 | 1 | |a Liu, Ya |e verfasserin |4 aut | |
700 | 1 | |a Pan, Zhilin |e verfasserin |4 aut | |
700 | 1 | |a Mitchell, David T |e verfasserin |4 aut | |
700 | 1 | |a Wu, Fengchun |e verfasserin |4 aut | |
700 | 1 | |a Zhang, Xiang Yang |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Scientific reports |d 2011 |g 10(2020), 1 vom: 30. Sept., Seite 16119 |w (DE-627)NLM215703936 |x 2045-2322 |7 nnns |
773 | 1 | 8 | |g volume:10 |g year:2020 |g number:1 |g day:30 |g month:09 |g pages:16119 |
856 | 4 | 0 | |u http://dx.doi.org/10.1038/s41598-020-72934-3 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 10 |j 2020 |e 1 |b 30 |c 09 |h 16119 |